PL373539A1 - Polimorficzne postaci lanzoprazolu i sposoby ich wytwarzania - Google Patents

Polimorficzne postaci lanzoprazolu i sposoby ich wytwarzania

Info

Publication number: PL373539A1
Authority: PL; Poland
Prior art keywords: lansoprazole; polymorphs; processes; preparation; lansoprazole polymorphs
Prior art date: 2002-03-27

Application number

PL03373539A

Other languages

English (en)

Inventor

Nina Finkelstein

Shlomit Wizel

Original Assignee

Teva Pharmaceutical Industries Ltd.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-03-27

Filing date

2003-03-27

Publication date

2005-09-05

2003-03-27 Application filed by Teva Pharmaceutical Industries Ltd. filed Critical Teva Pharmaceutical Industries Ltd.

2005-09-05 Publication of PL373539A1 publication Critical patent/PL373539A1/pl

Links

MJIHNNLFOKEZEW-UHFFFAOYSA-N lansoprazole Chemical compound CC1=C(OCC(F)(F)F)C=CN=C1CS(=O)C1=NC2=CC=CC=C2N1 MJIHNNLFOKEZEW-UHFFFAOYSA-N 0.000 title 1
229960003174 lansoprazole Drugs 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

PL03373539A 2002-03-27 2003-03-27 Polimorficzne postaci lanzoprazolu i sposoby ich wytwarzania PL373539A1 (pl)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US36782002P	2002-03-27	2002-03-27

Publications (1)

Publication Number	Publication Date
PL373539A1 true PL373539A1 (pl)	2005-09-05

Family

ID=28675405

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL03373539A PL373539A1 (pl)	2002-03-27	2003-03-27	Polimorficzne postaci lanzoprazolu i sposoby ich wytwarzania

Country Status (15)

Country	Link
US (1)	US20040010151A1 (pl)
EP (1)	EP1476442A2 (pl)
JP (1)	JP2005533755A (pl)
KR (1)	KR20040093187A (pl)
CN (1)	CN1681802A (pl)
AU (1)	AU2003224779A1 (pl)
CA (1)	CA2480352A1 (pl)
HR (1)	HRP20040979A2 (pl)
IL (1)	IL164153A0 (pl)
IS (1)	IS7467A (pl)
MX (1)	MXPA04009384A (pl)
NO (1)	NO20044606L (pl)
PL (1)	PL373539A1 (pl)
WO (1)	WO2003082857A2 (pl)
ZA (1)	ZA200407799B (pl)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5840737A (en)	1996-01-04	1998-11-24	The Curators Of The University Of Missouri	Omeprazole solution and method for using same
US6489346B1 (en) *	1996-01-04	2002-12-03	The Curators Of The University Of Missouri	Substituted benzimidazole dosage forms and method of using same
US6645988B2 (en) *	1996-01-04	2003-11-11	Curators Of The University Of Missouri	Substituted benzimidazole dosage forms and method of using same
US6699885B2 (en) *	1996-01-04	2004-03-02	The Curators Of The University Of Missouri	Substituted benzimidazole dosage forms and methods of using same
WO2004035052A1 (ja) *	2002-10-16	2004-04-29	Takeda Pharmaceutical Company Limited	安定な固形製剤
CA2787378C (en)	2004-09-13	2015-11-03	Takeda Pharmaceutical Company Limited	Method for producing lansoprazole crystal
EP1681056A1 (en)	2005-01-14	2006-07-19	Krka Tovarna Zdravil, D.D., Novo Mesto	Process for preparing lansoprazole
KR100758600B1 (ko) *	2006-01-05	2007-09-13	주식회사 대웅제약	란소프라졸 결정형 ａ의 제조방법
JP2008543953A (ja) *	2006-04-20	2008-12-04	テバファーマシューティカルインダストリーズリミティド	エスゾピクロン結晶形態ａ、実質的に純粋なエスゾピクロン及び光学的に豊富なエスゾピクロンを調製するための方法
WO2008068767A2 (en) *	2006-12-07	2008-06-12	Hetero Drugs Limited	A novel crystalline form of lansoprazole
CN101687848B (zh)	2006-12-29	2013-05-15	一洋药品株式会社	外消旋艾普拉唑的固体形式
IT1391758B1 (it) *	2008-11-11	2012-01-27	Dipharma Francis Srl	Procedimento per la preparazione di dexlansoprazolo amorfo
IT1392813B1 (it) *	2009-02-06	2012-03-23	Dipharma Francis Srl	Forme cristalline di dexlansoprazolo
KR20100101405A (ko) *	2009-03-09	2010-09-17	한미홀딩스 주식회사	비결정형의 (+)-란소프라졸 제조방법 및 이에 사용되는 (+)-란소프라졸 알코올레이트
WO2011004387A2 (en) *	2009-06-18	2011-01-13	Matrix Laboratories Ltd	Process for the preparation of dexlansoprazole polymorphic forms
CN102108076B (zh) *	2009-12-23	2014-07-23	江苏豪森医药集团有限公司	制备无定形右兰索拉唑的方法
WO2011121548A1 (en) *	2010-03-31	2011-10-06	Ranbaxy Laboratories Limited	Process for the preparation of dexlansoprazole
WO2012095859A1 (en) *	2011-01-12	2012-07-19	Hetero Research Foundation	Polymorphs of dexlansoprazole salts
MY180626A (en)	2013-11-15	2020-12-03	Akebia Therapeutics Inc	Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof
CN103664889B (zh) *	2013-12-19	2014-11-19	悦康药业集团有限公司	一种兰索拉唑化合物
CN104844576B (zh) *	2015-04-28	2017-03-08	山东罗欣药业集团股份有限公司	一种兰索拉唑或右旋兰索拉唑晶型化合物及其制备方法
CN104829594A (zh) *	2015-05-15	2015-08-12	苗怡文	一种治疗胃溃疡的药物兰索拉唑化合物
CN104958276A (zh) *	2015-07-30	2015-10-07	青岛蓝盛洋医药生物科技有限责任公司	一种治疗胃溃疡的药物兰索拉唑组合物胶囊
CN104997738A (zh) *	2015-08-10	2015-10-28	青岛蓝盛洋医药生物科技有限责任公司	一种治疗胃病的药物兰索拉唑组合物干混悬剂
CN107011328B (zh) *	2017-05-05	2019-10-15	广州大光制药有限公司	一种兰索拉唑化合物的晶型及其结晶制备方法
CN108794450B (zh) *	2018-07-24	2022-08-19	浙江恒康药业股份有限公司	制备无定型右旋兰索拉唑的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK171989B1 (da) *	1987-08-04	1997-09-08	Takeda Chemical Industries Ltd	Fremgangsmåde til fremstilling af 2-(2-pyridylmethylsulfinyl)-benzimidazoler
TW385306B (en) *	1996-11-14	2000-03-21	Takeda Chemical Industries Ltd	Method for producing crystals of benzimidazole derivatives
TWI275587B (en) *	1999-06-17	2007-03-11	Takeda Chemical Industries Ltd	A crystal of (R)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl]sulfinyl]-1H-benzimidazole
PL333847A1 (en) *	1999-06-18	2001-01-02	Inst Farmaceutyczny	Crystalline forms of lansoprozole and method of obtaining lansoprazole in pharmacologically advanthageous crystalline form
ATE298334T1 (de) *	1999-06-30	2005-07-15	Takeda Pharmaceutical	Kristalle von lansoprazole
KR20100002278A (ko) *	2000-12-01	2010-01-06	다케다 야쿠힌 고교 가부시키가이샤	(ｒ)- 또는 (ｓ)-란소프라졸의 결정
EP1970374A1 (en) *	2001-02-02	2008-09-17	Teva Pharmaceutical Industries Ltd.	Process for the production of substituted 2-(pyridin-2-ylmethylsulfinyl)-1H-benzimidazoles

2003
- 2003-03-27 KR KR10-2004-7015088A patent/KR20040093187A/ko not_active Ceased
- 2003-03-27 IL IL16415303A patent/IL164153A0/xx unknown
- 2003-03-27 HR HR20040979A patent/HRP20040979A2/hr not_active Application Discontinuation
- 2003-03-27 MX MXPA04009384A patent/MXPA04009384A/es not_active Application Discontinuation
- 2003-03-27 US US10/401,057 patent/US20040010151A1/en not_active Abandoned
- 2003-03-27 EP EP03721469A patent/EP1476442A2/en not_active Withdrawn
- 2003-03-27 CA CA002480352A patent/CA2480352A1/en not_active Abandoned
- 2003-03-27 CN CNA038120372A patent/CN1681802A/zh active Pending
- 2003-03-27 JP JP2003580323A patent/JP2005533755A/ja active Pending
- 2003-03-27 PL PL03373539A patent/PL373539A1/pl not_active Application Discontinuation
- 2003-03-27 WO PCT/US2003/009261 patent/WO2003082857A2/en not_active Ceased
- 2003-03-27 AU AU2003224779A patent/AU2003224779A1/en not_active Abandoned
2004
- 2004-09-23 IS IS7467A patent/IS7467A/is unknown
- 2004-09-28 ZA ZA200407799A patent/ZA200407799B/en unknown
- 2004-10-26 NO NO20044606A patent/NO20044606L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
AU2003224779A1 (en)	2003-10-13
CN1681802A (zh)	2005-10-12
WO2003082857A2 (en)	2003-10-09
IL164153A0 (en)	2005-12-18
JP2005533755A (ja)	2005-11-10
MXPA04009384A (es)	2005-01-25
NO20044606L (no)	2004-10-26
KR20040093187A (ko)	2004-11-04
ZA200407799B (en)	2006-07-26
US20040010151A1 (en)	2004-01-15
HRP20040979A2 (en)	2005-06-30
IS7467A (is)	2004-09-23
WO2003082857A3 (en)	2003-12-18
CA2480352A1 (en)	2003-10-09
EP1476442A2 (en)	2004-11-17

Legal Events

Date	Code	Title	Description
2012-01-31	REFS	Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)

Publication	Publication Date	Title
IL164153A0 (en)	2005-12-18	Lansoprazole polymorphs and processes for preparation thereof
IL175647A0 (en)	2006-09-05	Composition and method for enhancing bioavailability
GB2400918B (en)	2006-04-12	Viscosity-change-detecting apparatus
GB0202319D0 (en)	2002-03-20	Apparatus
GB0222855D0 (en)	2002-11-06	Sampling apparatus
GB0223098D0 (en)	2002-11-13	Medicinal apparatus
EP1550508A4 (en)	2009-12-09	APPARATUS FOR SPRAYING SUBSTANCE
GB0221438D0 (en)	2002-10-23	Processes and compounds
AU2003281698A8 (en)	2004-02-16	1-phenylpiperidin-3-one derivatives and processes for the preparation thereof
GB0203182D0 (en)	2002-03-27	Apparatus
IL164407A0 (en)	2005-12-18	Processes for preparing heteroaryl and unsaturatedheterocycloalkylmagnesium compounds
GB0223965D0 (en)	2002-11-20	Apparatus
GB0222203D0 (en)	2002-10-30	Apparatus
GB0215867D0 (en)	2002-08-14	Novel method and compounds
IL165030A0 (en)	2005-12-18	Compound and processes for the preparation and usethereof
GB2396361B (en)	2006-03-29	Flood-prevention apparatus
EP1474211A4 (en)	2006-08-30	IMPROVED TJOSA DEVICE
GB0226194D0 (en)	2002-12-18	Pharmaceutical research method
HU2367U (en)	2002-08-28	Apparatus for covering of gutter-structure
GB0214083D0 (en)	2002-07-31	Improved apparatus
HU0200005V0 (en)	2002-03-28	Apparatus for pair-hunter
GB0200596D0 (en)	2002-02-27	Self-drive apparatus
PL353382A1 (en)	2003-01-13	Set for teleshooting
TW537204U (en)	2003-06-11	Trans-printing apparatus
GB0326658D0 (en)	2003-12-17	Debagging apparatus